( – FocusAsia Media Ltd

SHANGHAI, Aug 10 (FAM) – Shanghai Pharma, one of China’s largest listed pharmaceuticals groups, has signed a Memorandum of Understanding (MOU) with contract logistics solutions specialist, DHL Supply Chain, to prepare its logistics infrastructure for rapid global expansion.

Under the MOU, the pharmaceuticals giant – which generated revenues of more than
US$18 billion (RMB121 billion) last year  – will partner with DHL Supply Chain to enhance quality control measures, streamline distribution processes, and strengthen compliance with local and international food and pharmaceutical regulations.